Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Palisade Bio Inc shares valued at $4,863 were purchased by Williams Donald Allen on May 28 ’24. At $4.86 per share, Williams Donald Allen acquired 1,000 shares. The insider’s holdings grew to 1,000 shares worth approximately $2360.0 following the completion of this transaction.
Also, Finley John David purchased 1,000 shares, netting a total of over 4,810 in proceeds. Following the buying of shares at $4.81 each, the insider now holds 8,437 shares.
Before that, Finley John David had added 10,000 shares to its account. In a trade valued at $4,692, the CEO, CFO, Director bought Palisade Bio Inc shares for $0.47 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.2 million.
Analyzing PALI Stock Performance
During the last five days, there has been a surge of approximately 34.86%. Over the course of the year, Palisade Bio Inc shares have dropped approximately -73.33%. Shares of the company reached a 52-week high of $22.3500 on 01/29/24 and a 52-week low of $1.3800 on 12/11/24. A 50-day SMA is recorded $2.8100, while a 200-day SMA reached $4.3000. Nevertheless, trading volume fell to 68.0 million shares from 0.65 million shares the previous day.
Support And Resistance Levels for Palisade Bio Inc (PALI)
According to the 24-hour chart, there is a support level at 1.7500, which, if violated, would cause prices to drop to 1.1300. In the upper region, resistance lies at 3.1400. The next price resistance is at 3.9100. RSI (Relative Strength Index) is 51.19 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.3700, which suggests the price will decrease in the coming days. Percent R is at 48.96%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.
